Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Apr;595(8):1132-1158.
doi: 10.1002/1873-3468.14068. Epub 2021 Mar 21.

Genetic basis of mitochondrial diseases

Affiliations
Free article
Review

Genetic basis of mitochondrial diseases

Mirjana Gusic et al. FEBS Lett. 2021 Apr.
Free article

Abstract

Mitochondrial disorders are monogenic disorders characterized by a defect in oxidative phosphorylation and caused by pathogenic variants in one of over 340 different genes. The implementation of whole-exome sequencing has led to a revolution in their diagnosis, duplicated the number of associated disease genes, and significantly increased the diagnosed fraction. However, the genetic etiology of a substantial fraction of patients exhibiting mitochondrial disorders remains unknown, highlighting limitations in variant detection and interpretation, which calls for improved computational and DNA sequencing methods, as well as the addition of OMICS tools. More intriguingly, this also suggests that some pathogenic variants lie outside of the protein-coding genes and that the mechanisms beyond the Mendelian inheritance and the mtDNA are of relevance. This review covers the current status of the genetic basis of mitochondrial diseases, discusses current challenges and perspectives, and explores the contribution of factors beyond the protein-coding regions and monogenic inheritance in the expansion of the genetic spectrum of disease.

Keywords: diagnostics; genetics; metabolic disorders; mitochondrial disease; multiomics; noncoding; oxidative phosphorylation; variants.

PubMed Disclaimer

References

    1. Gorman GS, Chinnery PF, DiMauro S, Hirano M, Koga Y, McFarland R, Suomalainen A, Thorburn DR, Zeviani M and Turnbull DM (2016) Mitochondrial diseases. Nat Rev Dis Primers 2, 16080.
    1. Tan J, Wagner M, Stenton SL, Strom TM, Wortmann SB, Prokisch H, Meitinger T, Oexle K and Klopstock T (2020) Lifetime risk of autosomal recessive mitochondrial disorders calculated from genetic databases. EBioMedicine 54, 102730.
    1. Munnich A and Rustin P (2001) Clinical spectrum and diagnosis of mitochondrial disorders. Am J Med Genet 106, 4-17.
    1. Zhou J, Li J, Stenton SL, Ren X, Gong S, Fang F and Prokisch H (2020) NAD(P)HX dehydratase (NAXD) deficiency: a novel neurodegenerative disorder exacerbated by febrile illnesses. Brain 143, e8.
    1. El-Hattab AW, Zarante AM, Almannai M and Scaglia F (2017) Therapies for mitochondrial diseases and current clinical trials. Mol Genet Metab 122, 1-9.

Publication types

Substances

LinkOut - more resources